Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
all 184975 studies found for:    ALL
Show Display Options
Rank Status Study
21 Completed Motivational Interviewing to Promote Maintenance of Physical Activity in People With Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Behavioral: Motivational interviewing
22 Completed A Church Based Intervention to Improve Diabetes Care
Condition: Type 2 Diabetes
Intervention: Behavioral: diabetes self care (behavior)
23 Unknown  Analysis of Proinflammatory Factors in the Synovial Fluid In Patients With Rotator Cuff Disease
Condition: Rotator Cuff Disease
Intervention:
24 Not yet recruiting Comparison of Active and Passive Perioperative Warming Techniques in Reducing Intraoperative Blood Loss
Conditions: Hypothermia;   Blood Loss,;   Blood Coagulation Disorders
Intervention: Device: Bair Hugger forced air warming system
25 Completed The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease
Condition: Early Stage Parkinson's Disease
Interventions: Drug: Aplindore;   Drug: Placebo
26 Recruiting Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis Patients
Conditions: Pain;   Inflammation
Interventions: Drug: Parecoxib and Celecoxib;   Drug: placebo
27 Recruiting Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia
Condition: Staphylococcus Aureus Bacteraemia
Interventions: Drug: direct thrombin inhibition;   Drug: enoxaparin
28 Completed Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
Condition: Lymphoma
Interventions: Biological: Bleomycin Sulfate;   Biological: Filgrastim;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Doxorubicin Hydrochloride (DOX);   Drug: Etoposide;   Drug: Fluorouracil;   Drug: Ifosfamide;   Drug: Leucovorin calcium;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Pentamidine;   Drug: Prednisone;   Drug: Trimethoprim-Sulfamethoxazole;   Drug: Vincristine Sulfate;   Drug: Zidovudine (AZT);   Radiation: Radiation Therapy
29 Recruiting Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Conditions: Solid Tumors;   Non-Hodgkin's Lymphoma;   Multiple Myeloma;   Glioblastoma Multiforme;   Oligodendroglioma;   Hepatocellular Carcinoma;   Diffuse Large B-cell Lymphoma;   Mantle Cell Lymphoma
Intervention: Drug: CC-122 HCL
30 Completed Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults
Conditions: Meningococcal Meningitis, Serogroup A;   Meningococcal Meningitis, Serogroup B;   Meningococcal Meningitis, Serogroup C;   Meningococcal Meningitis, Serogroup Y;   Meningococcal Meningitis, Serogroup W
Intervention: Drug: meningococcal B vaccine & meningococcal ACYW conjugate vaccine
31 Unknown  Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma
Condition: Brain and Central Nervous System Tumors
Intervention: Biological: transferrin-CRM107
32 Completed A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer
Condition: Pain
Intervention: Drug: Hydromorphone
33 Recruiting Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
Condition: Multiple Sclerosis
Intervention:
34 Recruiting Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty
Condition: Saphenous Vein Graft Atherosclerosis
Interventions: Device: Bare Metal Stent;   Device: Drug-Eluting Stent;   Drug: Blinded clopidogrel;   Drug: Placebo;   Drug: Thienopyridine (open-label)
35 Unknown  Transbronchial Needle Forceps for Endobronchial Ultrasound
Conditions: Lung Cancer;   Lymph Nodes
Intervention: Procedure: EBUS TBNF
36 Completed A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)
Conditions: Alzheimer's Disease;   Huntington Disease
Interventions: Drug: Dimebon IR Tablet;   Drug: Dimebon MR1;   Drug: Dimebon MR2;   Drug: Dimebon MR3;   Drug: Dimebon MR4
37 Recruiting Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: PF-04965842;   Other: Placebo
38 Terminated Study of Vorinostat Plus Melphalan and Prednisone (Zmp) in Advanced, Refractory Multiple Myeloma Patients
Condition: Multiple Myeloma
Intervention: Drug: Vorinostat
39 Completed A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy
Conditions: Lung Cancer;   Tuberculosis;   Sarcoidosis;   Interstitial Lung Disease
Interventions: Drug: 1% lignocaine;   Drug: 2% lignocaine
40 Recruiting Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease
Condition: Peripheral Artery Disease
Interventions: Drug: Metformin 1000 mg;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years